Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy
Advanced Science · 2026-01 · 13 (2)
DOI: 10.1002/advs.202510854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.10.2025. Verfasst von Jiahao Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, P. R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immunotherapy, Tumor-Associated Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuxi Taihu Lake Talent Plan, Supports for Leading Talents in Medical and Health Profession, Scientific research project of Wuxi Municipal Health Commission.
Abstract (Originalsprache)
This study introduces the Sono@NAT10 nanorobot for colorectal cancer (CRC) immunotherapy, designed to target NAT10 condensates in macrophages. Sono@NAT10, enclosed in a macrophage membrane using a metal–organic framework, shows stability under acidic conditions and releases NAT10 siRNA upon ultrasound activation. Flow cytometry and confocal imaging confirm effective macrophage targeting. Sequencing and proteomics reveal that NAT10 regulates SRSF2 protein stability, thereby promoting the transition of macrophages from the M2 to the M1 phenotype. In a CRC mouse model, Sono@NAT10 combined with anti‐PD‐1 (CD279) antibody inhibited tumor growth and enhances survival. These findings demonstrate the potential of Sono@NAT10 as a novel immunotherapeutic strategy for CRC by modulating NAT10 phase separation, providing a foundation for further exploration of its clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, P. R. China.
- Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, P. R. China.
- Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, 215000, P. R. China.
ORCID-Profile: Yutian Zhao
Förderung
- Wuxi Taihu Lake Talent Plan
- Supports for Leading Talents in Medical and Health Profession
- Scientific research project of Wuxi Municipal Health Commission
Zitieren
APA
Zhu, J., Xu, B., Hu, R., Yang, B., Shen, P., Xu, Y., Zhang, X., Qian, D., Wu, G., Ji, S., Zhao, Y., & Gu, K. (2026). Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy. Advanced Science, 13(2). https://doi.org/10.1002/advs.202510854
Vancouver
Zhu J, Xu B, Hu R, Yang B, Shen P, Xu Y, et al. Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy. Advanced Science. 2026;13(2). doi:10.1002/advs.202510854
BibTeX
@article{Zhu2026,
author = {Zhu, Jiahao and Xu, Benjie and Hu, Rui and Yang, Bo and Shen, Peipei and Xu, Yu and Zhang, Xiaojun and Qian, Danqi and Wu, Gang and Ji, Shengjun and Zhao, Yutian and Gu, Ke},
title = {Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {2},
doi = {10.1002/advs.202510854}
}
EUVIMED